ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979

Lippman Named UCSD Cancer Center Director

May 4, 2012

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005